Abstract
Arsenical keratoses may disclose a cryptic exposure to arsenic many years earlier. Such lesions usually appear on the palms and soles, as they do elsewhere, as cornlike, hard, yellowish papules, with a predisposition along sites of trauma and friction. These lesions may coalesce into verrucous plaques and may evolve into full-thickness dysplasia, or Bowen’s disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Hutchinson J: Arsenic cancer. Br Med J 1887; 2:1280–1281.
Jackson R, Grainge JW: Arsenic and cancer. Can Med J 1975; 113:396–401.
Benson AA, Summons RE: Arsenic accumulation in great Barrier Reef invertebrates. Science 1981; 211:482–483.
Walkiw O, Douglas DE: Health food supplements prepared from kelp, a source of elevated urinary arsenic. Can Med J 1974; 111:1301–1302.
Peters HA, Crost WA, Woolson EA, et al: Seasonal arsenic exposure from burning chromium-copper-arsenate-treated wood. JAMA 1984; 251:2393–2396.
Southwick GJ, Schwartz RA: Arsenically associated cutaneous squamous cell carcinoma with hypercalcemia. J Surg Oncol 1979; 12:115–118.
Rubenstein DJ, Schwartz RA, Hansen RC, et al: Punctate hyperkeratosis of the palms and soles: An ultrastructural study. J Am Acad Dermatol 1980; 3:43–50.
Chen C-J, Chuang Y-C, You T-M, et al: A retrospective study on malignant neoplasms of bladder and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 1986; 55:399–405.
Schoolmeester WL, White DR: Arsenic poisoning. South Med J 1980; 73:198–208.
Prystowsky SD, Elfenbein GJ, Lamberg SI: Nasopharyngeal carcinoma associated with long-term arsenic ingestion. Arch Dermatol 1978; 114:602–603.
Shneidman D, Belizaire R: Arsenic exposure followed by the development of dermatofibrosar-coma protuberans. Cancer 1986; 58:1585–1587.
Miki Y, Kawatus T, Matsuda K, et al: Cutaneous and pulmonary cancer associated with Bowen’s disease. J Am Acad Dermatol 1982; 6:26–31.
Yeh S: Skin cancer in chronic arsenicism. Human Pathol 1973; 4:469–485.
Brownstein MH, Rabinowitz AD: The precursors of cutaneous squamous cell carcinoma. Int J Dermatol 1979; 18:1–16.
Leslie ACD, Smith H: Napoleon Bonaparte’s exposure to arsenic during 1816. Arch Toxicol 1978; 41:163–167.
Thianprasit M: Chronic cutaneous arsenicism treated with aromatic retinoid. J Med Assoc Thai 1984; 67:93–100.
Bansal NK, Khare AK: Giant palmar cutaneous horns. Indian J Dermatol Venereol Leprol 1985; 51:186.
Bart RS, Andrade R, Kopf AW: Cutaneous horns: A clinical and histopathologic study. Acta Derm Venereol (Stockh) 1968; 48:507–515.
Lowe FC, McCullough AR: Cutaneous horns of the penis: An approach to management. Case report and review of the literature. J Am Acad Dermatol 1985; 13:369–373.
Schosser RH, Hodge SJ, Gaba CR, Owen LG: Cutaneous horns: A histopathologic study. South Med J 1979; 72:1129–1131.
Peterson JL, McMarlin SL: Metastatic renal-cell carcinoma presenting as a cutaneous horn. J Dermatol Surg Oncol 1983; 9:815–818.
Brauninger GE, Hood CI, Worthen DM: Sebaceous carcinoma of lid margin masquerading as cutaneous horn. Arch Ophthalmol 1973; 90:380–381.
Goette DK: Cutaneous horn overlying granular cell tumor. Internat J Dermatol 1987; 26:598–599.
Nakamura K: Two cases of trichilemmal-like horn. Arch Dermatol 1984; 120:386–387.
Pott P: Chirurgical Observations Relative to the Cataract, the Polypus of the Nose, the Cancer of the Scrotum, the Different Kinds of Ruptures, and Mortification of the Toes and Feet. London, Hawes, Clarke, Collins, 1775, pp 63–68.
Shambaugh P: Tar carcinoma of the lip in fisherman. JAMA 1935; 104:2326–2329.
Yuspa SH: Cutaneous chemical carcinogenesis. J Am Acad Dermatol 1986; 15:1031–1044.
Hodgson GA, Whiteley HJ: Personal susceptibility to pitch. Br J Ind Med 1970; 27:160–166.
Bowra GT, Duffield DP, Osborn AJ, Purchase IFH: Premalignant and neoplastic skin lesions associated with occupational exposure to “tarry” byproducts during manufacture of 4′,4′-bipyridyl. Br J Ind Med 1982; 39:76–81.
Bickers DR: The carcinogenicity and mutagenicity of therapeutic coal tar-a perspective. J Invest Dermatol 1981; 77:173–174.
Moy LS, Chalet M, Lowe NJ: Scrotal squamous cell carcinoma in a psoriatic patient treated with coal tar. J Am Acad Dermatol 1986; 14:518–519.
Mukhtar H, DelTito BJ Jr, Matgouranis PM, et al: Additive effects of ultraviolet B and crude coal tar on cutaneous carcinogen metabolism: Possible relevance to the tumorigenicity of the Goeckerman regimen. J Invest Dermatol 1986; 87:348–353.
Stern RS, Scotto J, Fears TR: Psoriasis and susceptibility to nonmelanoma skin cancer. J Am Acad Dermatol 1985; 12:67–73.
Hannuksela M, Stenback F, Lahti A: The carcinogenic properties of topical PUVA: A lifelong study in mice. Arch Dermatol Res 1986; 278:347–351.
Tanew A, Honigsmann H, Ortel B, et al: Non-melanoma skin tumors in long-term photochemotherapy treatment of psoriasis. J Am Acad Dermatol 1986; 15:960–965.
Henseler T, Christophers E, Hönigsmann H, et al: Skin tumors in the European PUVA study: Eight-year followup of 1,643 patients treated with PUVA for psoriasis. J Am Acad Dermatol 1987; 16:108–116.
Marks F, Furstenberger G: Experimental evidence that skin carcinogenesis is a multistep phenomenon. Br J Dermatol 1986; 115:(Suppl 31) 1–8.
Arrington JH III, Lockman DS: Thermal keratoses and squamous cell carcinoma in situ associated with erythema ab igne. Arch Dermatol 1979; 115:1226–1228.
Treves N, Pack GT: The development of cancer in burn scars. An analysis and report of 34 cases. Surg Gynecol Obstet 1930; 51:749–782.
Cross F: On a turf (peat) fire cancer: Malignant change superimposed on erythema ab igne. Proc R Soc Med 1967; 60:1307–1308.
Kligman LH: Intensification of ultraviolet-induced dermal damage by infrared radiation. Arch Dermatol Res 1982; 272:229–238.
Schwartz RA: Infrared radiation as a carcinogenic agent. Br J Dermatol 1978; 99:460–461.
Walter J: Epithelioma and papilloma arising on recently irradiated skin. Report of three cases. Br Med J 1950; 1:273–275.
Baer RL, Kopf AW: Complications of therapy of basal cell epitheliomas, in Baer RL, Kopf AW (Eds): Yearbook of Dermatology 1964–1965. Chicago, Yearbook Medical Publishers, 1965, pp 7–26.
Schwartz RA, Burgess GH, Milgrom H: Breast carcinoma and basal cell epithelioma after x-ray therapy for hirsutism. Cancer 1979; 44:1601–1605.
Kuwano H, Hashimoto H, Enjoji M: Atypical fibroxanthomas distinguishable from spindle cell carcinoma in sarcoma-like skin lesions. A clinicopathologic and immunohistochemical study of 21 cases. Cancer 1985; 55:172–180.
Yamamoto Y, Arata J, Yonezawa S: Angiomatoid malignant fibrous histiocytoma associated with marked bleeding arising in chronic radiodermatitis. Arch Dermatol 1985; 121:275–276.
Leone RA: Radiodermatitis caused by a radioactive gold ring. JAMA 1968; 206:2113–2114.
Stearns FW: The curious case of the radioactive ring. J Am Acad Dermatol 1981; 5:696–697.
Wells AD, Pryor JP: Radiation-induced carcinoma of the penis. Br J Urol 1986; 58:325–326.
Dabski K, Stoll HL Jr: Skin cancer caused by Grenz rays. J Surg Oncol 1986; 31:87–93.
Lindelöf B, Eklund G: Incidence of malignant skin tumors in 14, 140 patients after Grenz-ray treatment for benign skin disorders. Arch Dermatol 1986; 122:1391–1395.
Stromberg BV, Keiter JE, Wray RC, Weeks PM: Scar carcinoma: Prognosis and treatment. South Med J 1977; 70:821–822.
Mora RG, Perniciaro C: Cancer of the skin in blacks: I. A review of 163 black patients with cutaneous squamous cell carcinoma. J Am Acad Dermatol 1981; 5:535–543.
Sedlin ED, Fleming JL: Epidermoid carcinoma arising in chronic, osteomyelitic foci. J Bone Joint Surg 1963; 45A:827–838.
Hill JA, Battifora HA, Milgram JW: Spindle cell carcinoma arising in chronic osteomyelitis. Bull Hosp Joint Dis 1979; 34:187–195.
Handlers JP, Abrams AM, Aberle AM, et al: Squamous cell carcinoma of the lip developing in discoid lupus erythematosus. Oral Surg, Oral Med, Oral Pathol 1985; 60:382–386.
Whipp MJ, Harrington CI, Dundas S: Fatal squamous cell carcinoma associated with acne conglobata in a father and daughter. Br J Dermatol 1987; 117:389–392.
Lerner HJ, Deitrick G: Squamous-cell carcinoma of the pilonidal sinus: Report of a case and review of the literature. J Surg Oncol 1979; 11:177–183.
Katsas A, Agnantis J, Symrnis S, Kakavoulis T: Carcinoma on old frostbites. Am J Surg 1977; 133:377–378.
Marmelzat WL: Malignant tumors in smallpox vaccination scars: A report of 24 cases. Arch Dermatol 1968; 97:400–406.
Curry SS, Gaither DH, King LE Jr: Squamous cell carcinoma arising in dissecting perifolliculitis of the scalp. J Am Acad Dermatol 1981; 4:673–678.
Mauro JA, Stein AA: Squamous cell carcinoma of nail bed in hereditary ectodermal dysplasia. NY State J Med 1972; 72:1065–1066.
Chernosky ME: Porokeratosis. Arch Dermatol 1986; 122:869–870.
Idemori M, Arao T: Erythema elevatum diutinum developing squamous cell carcinoma. J Dermatol (Tokyo) 1979; 6:75–80.
Caplan RM: Epidermoid carcinoma arising in extensive chromoblastomycosis. Arch Dermatol 1968; 97:38–41.
Williamson DM: Chronic hyperplastic candidiasis and squamous carcinoma. Br J Dermatol 1969; 81:125–127.
Schwartz RA, Birnkrant AP, Rubenstein DJ, et al: Squamous cell carcinoma in dominant type epidermolysis bullosa dystrophica. Cancer 1981; 47:615–620.
Monk BE, Pembroke AC: Epidermolysis bullosa with squamous cell carcinoma. Clin Exper Dermatol 1987; 12:373–374.
Bernstein A, Scardino PT, Tomaszewski M-M, Cohen MT: Carcinoma arising in a branchial cleft cyst. Cancer 1976; 37:2417–2422.
Mahomed Y, Mandel MA, Cramer SF, Michel B: Squamous cell carcinoma arising in pemphigus vulgaris during immunosuppressive therapy. Cancer 1980; 46:1374–1377.
Krutchoff DJ, Cutler L, Laskowski S: Oral lichen planus: The evidence regarding potential malignant transformation. J Oral Pathol 1976; 7:1–7.
Yesudian P, Rao R: Malignant transformation of hypertrophic lichen planus. Int J Dermatol 1985; 24:177–178.
Pasieczny TAH: The treatment of balanitis xerotica obliterans with testerone propionate ointment. Acta Derm Venereol (Stockh) 1977; 57:275–277.
Bissada NK, Morcos RR, El-Senoussi M: Post-circumcision carcinoma of the penis: I. Clinical aspects. J Urol 1986; 135:283–285.
Swint RB, Klaus SN: Malignant degeneration of an epithelial nevus. Arch Dermatol 1970; 101:56–58.
Bauer F: Quinacrine hydrochloride drug eruption (tropical lichen planus). Its early and late sequalae and its malignant potential: A review. J Am Acad Dermatol 1981; 4:239.
Montgomery H: Precancerous dermatosis and epithelioma in situ. Arch Dermatol Syphilol 1939; 39:387–408.
Civatte J: Pseudo-carcinomatous hyperplasia. J Cutan Pathol 1985; 12:214–223.
Wagner RF Jr, Grande DJ: Pseudoepitheliomatous hyperplasia vs. squamous cell carcinoma arising from chronic osteomyelitis of the humerus. J Dermatol Surg Oncol 1986; 12:632–635.
Armin AR, Eng AM, Warpeha RL: Infiltrating squamous metaplasia in debrided skin. J Assoc Military Dermatol 1986; 12(1): 18–19.
Schwartz RA, Klein E: Ultraviolet light-induced carcinogenesis, in Holland JF, Frei E III (Eds): Cancer Medicine (2nd ed). Philadelphia, Lea & Febiger, 1982, pp 109–119.
Lambert WC, Andrews AD, German J, Kraemer KH: Xeroderma pigmentosum, in Thiers BH, Dobson RL (Eds): Pathogenesis of Skin Disease. New York, Churchill Livingstone, 1986, pp 579–599.
Lambert WC: Genetic diseases associated with DNA and chromosomal instability. Dermatol Clin 1987; 5:85–108.
Jung EG: Xeroderma pigmentosum. Int J Dermatol 1986; 25:629–633.
Kraemer KH, Lee MM, Scotto J: Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalitis in 830 published cases. Arch Dermatol 1987; 123:241–250.
Goldman L, Richfield DF, Loutzenhiser J, Haniszko G: Features uncommon to xeroderma pigmentosum. Case report with a study of 92 biopsy specimens. Arch Dermatol 1961; 83:272–276.
Patterson JW, Jordan WP Jr: Atypical fibroxanthoma in a patient with xeroderma pigmentosum. Arch Dermatol 1987; 123:1066–1070.
English JSC, Swerdlow AJ: The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117:457–461.
Lambert WC, Lambert MW: Co-recessive inheritance: A model for DNA repair, genetic disease and carcinogenesis. Mutat Res 1985; 145: 227–234.
Wade MH, Plotnick H: Xeroderma pigmentosum and squamous cell carcinoma of the tongue. Identification of two black patients as members of complementation group C. J Am Acad Dermatol 1985; 12:515–521.
Cleaver JE: DNA repair and replication in xeroderma pigmentosum and related disorders. Basic Life Sci 1986; 39:425–438.
Wysenbeek AJ, Weiss H, Duczyminer-Kahana M, et al: Immunologic alterations in xeroderma pigmentosum patients. Cancer 1986; 58:219–221.
Regan JD, Setlow RB, Kaback MM, Howell RR, Klein E, Burgess G: Xeroderma pigmentosum: A rapid sensitive method for prenatal diagnosis. Science 1971; 174:150–153.
Goldstein N, Hay-Roe V: Prevention of skin cancer with a PABA in alcohol sunscreen in xeroderma pigmentosum. Cutis 1975; 15:61–64.
Lutzner MA: Epidermodysplasia verruciformis. An autosomal recessive disease characterized by viral warts and skin cancer. A model for viral oncogenesis. Bull Cancer (Paris) 1978; 65:169–182.
Jablonska S, Orth G, Jarzabek-Chorzelska M, et al: Immunological studies in epidermodysplasia verruciformis. Bull Cancer (Paris) 1978; 65:183–190.
Van Voorst Vader PC, Orth G, Dutronquay V, et al: Epidermodysplasia verruciformis. Acta Derm Venereol (Stockh) 1986; 66:231–236.
Jablonska S, Obalek S, Orth G, et al: Regression of the lesions of epidermodysplasia verruciformis. Br J Dermatol 1982; 107:109–116.
Tanigaki T, Kanda R, Sato K: Epidermodysplasia verruciformis (L-L, 1922) in a patient with systemic lupus erythematosus. Arch Dermatol Res 1986; 278:247–248.
Sait MA, Garg BR: Case of epidermodysplasia verruciformis with a 12-year-follow-up. J Dermatol (Tokyo) 1986; 13:297–300.
Maeda K, Jimbow K, Fukushima M, et al: Epidermodysplasia verruciformis associated with Bowen’s disease, B lymphocytopenia and decreased immune functions. Dermatologica 1985; 171:478–485.
Majewski S, Skopinska-Rozewska E, Jablonska S, et al: Partial defects of cell-mediated immunity in patients with epidermodysplasia verruciformis. J Am Acad Dermatol 1986; 15:966–973.
Haftek M, Jablonska S, Szymanczyk J, Jarzabek-Chorzelska M: Langerhans cells in epidermodysplasia verruciformis. Dermatologica 1987; 174:173–179.
Jablonska S, Obalek S, Wolska H: Follow-up of patients with epidermodysplasia verruciformis treated with etretinate. Dermatologica 1986; 173:196–201.
Kowalzick L, Mensing H: Failure of etretinate in epidermodysplasia verruciformis. Dermatologica 1986; 173:75–78.
van Voorst Vader PC, de Jong MCJM, Blanken R, et al: Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics. Arch Dermatol Res 1987; 279:366–373.
Yambe H, Oikawa O, Jimbow K: Epidermodysplasia verruciformis: Clinical regression and increased cellular immunity induced by OK 432 treatment. J Dermatol 1985; 12:183–190.
Androphy EJ, Dvoretzky I, Maluish AE, et al: Response of warts in epidermodysplasia verruciformis to treatment with systemic and intrale-sional alpha interferon. J Am Acad Dermatol 1984; 11:197–202.
Okoro AN: Albinism in Nigeria. A clinical and social study. Br J Dermatol 1975; 92:485–492.
Luande J, Henschke CI, Mohammed N: The Tanzanian human albino skin: Natural history. Cancer 1985; 55:1823–1828.
McFadden AW: Skin disease in the Cuña Indians. Arch Dermatol 1961; 84:1013–1023.
Stoll DB, Ruschak P, Kauh Y, et al: Lentigo maligna in a woman with occulocutaneous albinism. Arch Dermatol 1981; 117:360–361.
Wood C, Graham D, Willsen J, Strefling A: Albinism in amelanotic melanoma. Arch Dermatol 1982; 118:283–284.
Pehamberger H, Honigsmann H, Wolff K: Dysplastic nevus syndrome with multiple primary amelanotic melanomas in oculocutaneous albinism. J Am Acad Dermatol 1984; 11:731–735.
Ellis CN, Voorhees JJ: Etretinate therapy. J Am Acad Dermatol 1987; 16:267–291.
Rights and permissions
Copyright information
© 1988 Springer-Verlag New York Inc.
About this chapter
Cite this chapter
Schwartz, R.A. (1988). Other Premalignant Cutaneous Dysplasias. In: Skin Cancer. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-3790-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4612-3790-7_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-8352-2
Online ISBN: 978-1-4612-3790-7
eBook Packages: Springer Book Archive